Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate the efficacy of maternal and infant perinatal antiretroviral
prophylaxis intensification for the prevention of mother-to-child intrapartum transmission of
HIV-1 in women receiving less than 8 weeks of antiretroviral prophylaxis during pregnancy.
Phase:
Phase 3
Details
Lead Sponsor:
Institut de Recherche pour le Developpement
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Harvard School of Public Health Harvard School of Public Health (HSPH)